| Cancer stem cell targeted therapy: progress amid controversies T Wang, S Shigdar, MP Gantier, Y Hou, L Wang, Y Li, H Al Shamaileh, ... Oncotarget 6 (42), 44191, 2015 | 173 | 2015 |
| Aptamers as theranostic agents: modifications, serum stability and functionalisation S Shigdar, J Macdonald, M O'Connor, T Wang, D Xiang, H Al. Shamaileh, ... Sensors 13 (10), 13624-13637, 2013 | 150 | 2013 |
| EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model T Wang, MP Gantier, D Xiang, AG Bean, M Bruce, SF Zhou, M Khasraw, ... Theranostics 5 (12), 1456, 2015 | 108 | 2015 |
| Challenges and opportunities for siRNA-based cancer treatment T Wang, S Shigdar, H Al Shamaileh, MP Gantier, W Yin, D Xiang, L Wang, ... Cancer letters 387, 77-83, 2017 | 106 | 2017 |
| Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery D Xiang, S Shigdar, AG Bean, M Bruce, W Yang, M Mathesh, T Wang, ... Theranostics 7 (17), 4071, 2017 | 77 | 2017 |
| Rapid one-step selection method for generating nucleic acid aptamers: Development of a DNA aptamer against α-bungarotoxin LH Lauridsen, HA Shamaileh, SL Edwards, E Taran, RN Veedu Public Library of Science 7 (7), e41702, 2012 | 68 | 2012 |
| Development of cell-specific aptamers: recent advances and insight into the selection procedures K Rahimizadeh, H AlShamaileh, M Fratini, M Chakravarthy, M Stephen, ... Molecules 22 (12), 2070, 2017 | 53 | 2017 |
| Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells H AlShamaileh, T Wang, D Xiang, W Yin, PHL Tran, RA Barrero, ... Scientific reports 7 (1), 5898, 2017 | 48 | 2017 |
| Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro M Chakravarthy, H AlShamaileh, H Huang, RK Tannenberg, S Chen, ... Chemical communications 54 (36), 4593-4596, 2018 | 43 | 2018 |
| A detailed protein-SELEX protocol allowing visual assessments of individual steps for a high success rate T Wang, W Yin, H AlShamaileh, Y Zhang, PHL Tran, TNG Nguyen, Y Li, ... Human gene therapy methods 30 (1), 1-16, 2019 | 35 | 2019 |
| Aptamer-mediated cancer gene therapy D Xiang, S Shigdar, G Qiao, SF Zhou, Y Li, M Q Wei, L Qiao, ... Current gene therapy 15 (2), 109-119, 2015 | 26 | 2015 |
| Integrative approaches in HIV‐1 non‐nucleoside reverse transcriptase inhibitor design V Poongavanam, V Namasivayam, M Vanangamudi, H Al Shamaileh, ... Wiley Interdisciplinary Reviews: Computational Molecular Science 8 (1), e1328, 2018 | 19 | 2018 |
| Nucleic acid aptamers as novel class of therapeutics to mitigate Alzheimer's disease pathology R K Tannenberg, H Al Shamaileh, L H Lauridsen, J R Kanwar, P R Dodd, ... Current Alzheimer Research 10 (4), 442-448, 2013 | 18 | 2013 |
| Inhibition of autophagy promotes the elimination of liver cancer stem cells by CD133 aptamer-targeted delivery of doxorubicin W Yin, CV Pham, T Wang, H Al Shamaileh, R Chowdhury, S Patel, Y Li, ... Biomolecules 12 (11), 1623, 2022 | 12 | 2022 |
| Next-Generation Nucleic Acid Aptamers with Two-Base-Modified Nucleotides Have Improved Binding Affinity and Potency. H AlShamaileh, RN Veedu ChemBioChem 18 (16), 1565–1567, 2017 | 8 | 2017 |
| Genomic signatures of barley breeding for environmental adaptation to the new continents H Hu, P Wang, TT Angessa, XQ Zhang, KJ Chalmers, G Zhou, CB Hill, ... Plant biotechnology journal 21 (9), 1719-1721, 2023 | 5 | 2023 |
| Cancer stem cell targeted therapy: progress amid controversies. Oncotarget. 2015; 6 (42): 44191–206 T Wang, S Shigdar, MP Gantier, Y Hou, L Wang, Y Li, HA Shamaileh, ... Epub 2015/10/27. doi: 10.18632/oncotarget. 6176..[PubMed: 26496035], 0 | 5 | |
| Xiang d T Wang, S Shigdar, HA Shamaileh, MP Gantier, W Yin Wang L, Zhou SF, Hou Y, Wang P, et al: challenges and opportunities for …, 2017 | 3 | 2017 |
| Stem-cell-specific aptamers for targeted cancer therapy HA Shamaileh, D Xiang, T Wang, W Yin, W Duan, S Shigdar Aptamers Tools for Nanotherapy and Molecular Imaging, 113-138, 2016 | 2 | 2016 |
| Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells (Scientific Reports,(2017), 7, 1,(5898), 10.1038/s41598-017 … H AlShamaileh, T Wang, D Xiang, W Yin, PHL Tran, RA Barrero, ... Scientific Reports 10, Article number: 22191, 2020 | 1 | 2020 |
